Genes and Diseases
Published by KeAi Communications Co.
ISSN : 2352-4820 eISSN : 2352-3042
Abbreviation : Gene Dis.
Aims & Scope
Genes & Diseases is an international journal for molecular and translational medicine.
The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases.
Publication formats include full length research article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases.
Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases.
The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 9.4 |
| 2024 | 6.90 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 2044 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 3080 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.646 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 63 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Preservation url
- Apc url
- License